IGSF9-SLAMF9 Fusion FISH Probe
The IGSF9-SLAMF9 Fusion FISH Probe is used to confirm a fusion of the IGSF9 and SLAMF9 genes. The fusion of the IGSF9 and SLAMF9 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| IGSF9-SLAMF9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| IGSF9-SLAMF9-20-AQAQ | 20 (40 μL) | 200 μL |
|
IGSF9 Gene Summary
The Immunoglobulin Superfamily Member 9 (IGSF9) gene is located on chr1 :159896828-159915386 at 1q23.2.
Gene Name: Immunoglobulin Superfamily Member 9
Chromosome: CHR1: 159896828 -159915386
Locus: 1q23.2
SLAMF9 Gene Summary
This gene encodes a member of the signaling lymphocytic activation molecule family. The encoded protein is a cell surface molecule that consists of two extracellular immunoglobulin domains, a transmembrane domain and a short cytoplasmic tail that lacks the signal transduction motifs found in other family members. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Apr 2009]
Gene Name: SLAM Family Member 9
Chromosome: CHR1: 159921281 -159924044
Locus: 1q23.2
Gene Diseases
The IGSF9 SLAMF9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|